Document 0454
 DOCN  M9550454
 TI    Differential reactivities of antibodies to HIV and HTLV-I in sera of
       suspected AIDS and ARC patients.
 DT    9505
 AU    Aidoo M; Nishiwaki O; Akari H; Brandful JA; Ampofo W; Hayami M; Ayisi
       NK; Noguchi Memorial Institute for Medical Research, University of;
       Ghana, Legon.
 SO    West Afr J Med. 1994 Jul-Sep;13(3):150-1. Unique Identifier : AIDSLINE
       MED/95143176
 AB    Sera collection from 255 clinically diagnosed AIDS and ARC patients were
       analyzed for antibodies to HIV and HTLV-I by Western blot and particle
       agglutination methods respectively. Antibodies to HIV were detected in
       37.3% of the sera collected as compared to 5.5% for HTLV-I. Most (95%)
       of the HIV positive sera had dual reactivity to both HIV-I and HIV-2.
       Antibodies to HTLV-1 were more frequently detected in HIV positive sera
       (11.58%) than in HIV negative sera (1.88%). Conversely, antibodies to
       HIV were detected twice as frequently in HTLV-1 positive sera (78.6%)
       than in HTLV-1 negative sera (34.85%).
 DE    Acquired Immunodeficiency Syndrome/DIAGNOSIS/EPIDEMIOLOGY/  *IMMUNOLOGY
       AIDS-Related Complex/DIAGNOSIS/EPIDEMIOLOGY/*IMMUNOLOGY  Blotting,
       Western  Comparative Study  Ghana/EPIDEMIOLOGY  Human  HIV
       Antibodies/*BLOOD  HIV Seroprevalence  HTLV-I Antibodies/*BLOOD
       Population Surveillance  Seroepidemiologic Methods  Support, Non-U.S.
       Gov't  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).